Transferrin receptor 1 in cancer: a new sight for cancer therapy.
Ying Shen(Northwestern Polytechnical University), Peng Shang(Tibet University), Bin Zhang(King Abdullah University of Science and Technology), Dandan Dong, Xin Li(Northwestern Polytechnical University), Yanru Xue(Northwestern Polytechnical University)
PubMed
January 1, 2018
Cited by 374
Related Papers
Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation
|Nature Communications|2016|597
Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs
|Cancer Letters|2020|586
Advances on Bioactive Polysaccharides from Medicinal Plants
|Critical Reviews in Food Science and Nutrition|2015|560
Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference–based bone anabolic strategy
|Nature Medicine|2015|355
Unraveling the Potential Role of Glutathione in Multiple Forms of Cell Death in Cancer Therapy
|Oxidative Medicine and Cellular Longevity|2019|318